StratumSkin science, cited
Ingredient Index

Dandruff & seborrheic dermatitis · Fungal acne

Selenium sulfide

Antifungal shampoo/lotion

Overall grade BTypical strength 2.5% shampoo (1.8% in some newer formulations)2 sources

Solid, placebo-beating evidence for dandruff, and genuinely good modern evidence for tinea versicolor. A 2022 double-blind trial found it worked about as well as ketoconazole. It also smells faintly of rotten eggs in some formulations, which nobody puts on the label. The jump to 'fungal acne on the chest and back' is, again, extrapolation from the same antifungal mechanism, not a claim anyone has actually tested in a trial.

Claim by claim

BDandruffA placebo-controlled trial of 246 people found both ketoconazole and selenium sulfide beat placebo. All reported adverse events were in the selenium sulfide arm, worth knowing before choosing between them.
BTinea versicolorA 2022 double-blind trial found selenium sulfide 1.8% and ketoconazole 2% had statistically equivalent mycological cure rates (94% vs 86%). It's good modern head-to-head evidence, though not placebo-controlled.
DFungal acne (body)No direct trial evidence. The only supporting data is a 1990s animal (guinea pig) study testing this alongside other antifungals, which is not human evidence.

References

  1. Danby FW, et al. A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff. Journal of the American Academy of Dermatology, 1993.BRandomised double-blind placebo-controlled trial, n=246·Placebo-controlled trial in moderate-to-severe dandruff. Both active arms beat placebo.PubMed 8245236
  2. Lusiana, Surachmiati L, Saldi SRF, Lusianingtyas T, Bramono K. The mycological efficacy and safety of selenium sulfide 1.8% versus ketoconazole 2% shampoo in pityriasis versicolor: a double-blind randomised controlled trial. Germs, 2022.BDouble-blind randomised controlled trial·Selenium sulfide and ketoconazole performed equivalently (94% vs 86% mycological cure, not a significant difference). An active-comparator trial, so it tells you the two are similarly effective, not how much better than nothing either one is.PubMed 38021181DOI 10.18683/germs.2022.1351

Your turn

Did this hold up? Tell us honestly — especially if it didn’t.

Anonymous. Stored in your browser.

The Sunday study

One paper a week, explained properly

We pick a single new study, tell you what it measured, how many people it measured it in, and whether it should change anything you're doing — plus the two articles we published that week. No panic, and no hype.

We don't recommend products yet. When we do, they'll be things you can actually buy in India, any affiliate link will be labelled as one, and a commission will never buy a recommendation.

One email each Sunday. Unsubscribe in one click.